The study adds to growing of evidence that GLP-1 drugs could offer broad health benefits and potentially help people live ...

Biotechnology The Dream of HIV Vaccines May Finally Be Coming True In a Phase 1 trial, up to 80 percent of people receiving an mRNA vaccine produced antibodies against HIV.